TBA-7371
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TBA-7371, covering 2024-04-11 to 2024-04-11. Get the full timeline:
Most recent: Clinical Trial Update: Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis [Phase 2]